ALX Oncology Holdings Inc
NASDAQ:ALXO

Watchlist Manager
ALX Oncology Holdings Inc Logo
ALX Oncology Holdings Inc
NASDAQ:ALXO
Watchlist
Price: 1.21 USD 11.01% Market Closed
Market Cap: 64.8m USD

Intrinsic Value

The intrinsic value of one ALXO stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.21 USD, ALX Oncology Holdings Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALXO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
ALX Oncology Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

ALXO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ALXO is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Compare ALXO to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALXO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ALX Oncology Holdings Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ALX Oncology Holdings Inc

Current Assets 85.3m
Cash & Short-Term Investments 79.3m
Receivables 638k
Other Current Assets 5.3m
Non-Current Assets 10.1m
Long-Term Investments 4.2m
PP&E 5.1m
Other Non-Current Assets 700k
Efficiency

Free Cash Flow Analysis
ALX Oncology Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ALX Oncology Holdings Inc

Revenue
0 USD
Operating Expenses
-118.5m USD
Operating Income
-118.5m USD
Other Expenses
1.9m USD
Net Income
-116.6m USD
Fundamental Scores

ALXO Profitability Score
Profitability Due Diligence

ALX Oncology Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

ALX Oncology Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ALXO Solvency Score
Solvency Due Diligence

ALX Oncology Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

ALX Oncology Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALXO Price Targets Summary
ALX Oncology Holdings Inc

Wall Street analysts forecast ALXO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALXO is 2.3 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

Lowest
Price Target
1.01 USD
17% Downside
Average
Price Target
2.3 USD
90% Upside
Highest
Price Target
3.15 USD
160% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ALX Oncology Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ALXO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ALXO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ALXO stock?

The intrinsic value of one ALXO stock under the Base Case scenario is hidden USD.

Is ALXO stock undervalued or overvalued?

Compared to the current market price of 1.21 USD, ALX Oncology Holdings Inc is hidden .

Back to Top